John J. Kirby is CFO at IDERA PHARMACEUTICALS, INC. (IDRA). They have made 6 open-market trades across 2 companies since 2020, most recently 2026-08-18.
CIK 0001556327
3 open-market purchases totalling $46K since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDRA | 436,850 | $3.2M |
| VRCA | 23,962 | $81K |
| VPHM | 1,980 | — |
| Total | $3.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRCA | BUY | 2026-08-18 | 2026-08-18 | $4.93 | $25K | +8.8% | -8.4% | — |
| VRCA | BUY | 2025-11-25 | 2025-11-25 | $4.24 | $15K | +45.9% | +46.8% | +0.9% |
| IDRA | BUY | 2021-12-17 | 2021-12-21 | $0.62 | $6K | -1.8% | +5.0% | -17.7% |
| IDRA | SELL | 2021-03-25 | 2021-03-29 | $1.42 | $9K | +2.3% | -4.6% | -0.8% |
| IDRA | SELL | 2021-01-12 | 2021-01-12 | $4.22 | $7K | +40.4% | +20.0% | -71.8% |
| IDRA | SELL | 2021-01-05 | 2021-01-06 | $3.90 | $3K | +34.7% | +31.4% | -67.3% |
| IDRA | SELL · 10b5-1 | 2020-01-07 | 2020-01-14 | $1.78 | $2K | -6.8% | -18.4% | -13.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.